A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

Completed · Phase 2 · Has a placebo group

Conditions studied: Migraine

In brief

This study is being conducted to evaluate the efficacy of a 91-day extended cycle oral contraceptive compared to placebo for decreasing the frequency and severity of menstrually-related migraine headaches.

Key facts

Study ID

NCT00781456

Run by

Duramed Research

People needed

109

Starts

2009-01-01

Expected to finish

2011-08-01

Last updated by the study team

2017-02-06

Who can join

Age: 18 and older, up to 34. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Premenopausal, non-pregnant, non-lactating
• History of migraine headaches without aura for at least 6 months
• History of migraine headaches associated with menstruation
• Others as directed by FDA-approved protocol

You may not qualify if…

• History of migraine headaches with aura or focal neurological symptoms
• Any contraindication to the use of oral contraceptives
• Others as dictated by FDA-approved protocol

Where it is running

• Teva Investigational Site — La Mesa, California, United States
• Duramed Investigational Site — San Diego, California, United States
• Teva Investigational Site — San Diego, California, United States
• Duramed Investigational Site — San Francisco, California, United States
• Duramed Investigational Site — Washington D.C., District of Columbia, United States
• Duramed Investigational Site — West Palm Beach, Florida, United States
• Teva Investigational Site — Savannah, Georgia, United States
• Duramed Investigational Site — Edison, New Jersey, United States
• Duramed Investigational Site — New York, New York, United States
• Teva Investigational Site — Winston-Salem, North Carolina, United States
• Teva Investigational Site — Tulsa, Oklahoma, United States
• Teva Investigational Site — Medford, Oregon, United States
• Duramed Investigational Site — Philadelphia, Pennsylvania, United States
• Teva Investigational Site — Uniontown, Pennsylvania, United States
• Teva Investigational Site — Columbia, South Carolina, United States
• Teva Investigational Site — Hilton Head, South Carolina, United States
• Teva Investigational Site — Memphis, Tennessee, United States
• Duramed Investigational Site — Dallas, Texas, United States
• Teva Investigational Site — Houston, Texas, United States
• Duramed Investigational Site — San Antonio, Texas, United States
• Duramed Investigational Site — Virginia Beach, Virginia, United States
• Duramed Investigational Site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.